Now the risk of death from cervical cancer will be reduced by 40%

New treatment for cervical cancer : The risk of cervical cancer is increasing rapidly not only in India but all over the world. According to the WHO, it is the fourth most common cancer among women, with approximately 6.6 million new cases occurring each year. Of them, 3.5 lakh die. There are around 3,200 cases of cervical cancer and 800 deaths each year in the UK.

Most of these affected women are around 30 years old. In such a situation, an effective treatment for this cancer has been found. After 10 years of testing, medical science has made great progress. The new treatment method will reduce the risk of death from cervical cancer by approximately 40%.

Also read: Health Tips: If you use the phone for a long time while sitting in the toilet, these serious illnesses may occur.

what is cervical cancer

Cervical cancer is caused by the human papillomavirus (HPV). There is a risk of infection with this virus if you have sex with multiple partners. You should be vigilant in case of vaginal bleeding, excessive discharge of fluid, foul odor and pain during physical intercourse. When such symptoms appear, tests are carried out by Pap smear, cervical biopsy and abdominal ultrasound.

What is the new treatment for cervical cancer?

A new treatment would be very effective in treating cervical cancer. This reduces the risk of death of patients by 40%, which is considered the best treatment for this disease in the last 25 years. In this new treatment, patients receive a short course of chemotherapy, after which they receive a combination of chemotherapy and radiotherapy. This treatment has been successfully tested for 10 years in the United Kingdom, Mexico, India, Italy and Brazil.

Also read: From excessive fatigue to weight loss, these are the five major symptoms of cancer.

What do the researchers say?

Researchers at University College London found that this new treatment not only reduced patients’ risk of death, but also reduced the risk of cancer recurrence by 35%. The research results were published in the Lancet magazine. Dr Mary McCormack, who led the tests, said: “This is the best treatment yet in the treatment of cervical cancer. »There is now a demand to distribute it worldwide. Dr Ian Fowles, executive director of Cancer Research UK, said: “This treatment is a new beacon of hope for cervical cancer patients.